Skip to main content
Clinical Trials/CTRI/2012/07/002761
CTRI/2012/07/002761
Recruiting
未知

Effect of atorvastatin on hyperlipidemia and progression of carotid intima media thickness in steroid resistance nephrotic syndrome: A randomized controlled trial

ICMR0 sites50 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Steroid Resistant Nephrotic Syndrome with hyperlipidemia
Sponsor
ICMR
Enrollment
50
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ICMR

Eligibility Criteria

Inclusion Criteria

  • 1\)Patient with LDL Cholesterol Between 130\-300mg/dl on 2 occassions at least one week apart.
  • 2\)Patient with stable dose of immunosuppressive medication (Prednisolone and Calcineurin inhibitors)for aperiod of 3 months.

Exclusion Criteria

  • 1\) History of jaundice in last 6 months: AST/ALT levels more than twice normal of upper limit of the laboratory reference value.
  • 2\) CPK levels more than 3 times normal.
  • 3\) Children on lipid lowering agents such asHMG CoA reductase inhibitors in the past 3 months.
  • 4\)Family History of premature CVD
  • 5\)Patients with secondary nephrotic syndrome(SLE,IgAN,MPGN,MGN Alports disease)
  • 6\)Patients on pulse corticosteroids or cyclophosphamide in last 6 months.
  • 7\)Patients with stage 2 hypertension.
  • 8\)GFR30ml/min/m2 or below
  • 9\)Children residing beyond 200km from delhi.

Outcomes

Primary Outcomes

Not specified

Similar Trials